{"name":"Eugene Y Rhee, MD","slug":"eugene-y-rhee-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Promescent Lidocaine Spray","genericName":"Promescent Lidocaine Spray","slug":"promescent-lidocaine-spray","indication":"Premature ejaculation","status":"phase_3"}]}],"pipeline":[{"name":"Promescent Lidocaine Spray","genericName":"Promescent Lidocaine Spray","slug":"promescent-lidocaine-spray","phase":"phase_3","mechanism":"Lidocaine spray topically anesthetizes nerve endings in penile tissue to reduce sensory stimulation and delay ejaculation.","indications":["Premature ejaculation"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxNQkZkaThHcmZDMTJ6ZGVtOGV1empVQnlJWnUzblRzWHY2cnRield5aHgtdWpkSnFFQzlBNEFJMG9qM1VHRlFkbkNqRmxrdzhTbXRMWjZWYWlKU3ltWDJXRmFEZ0E0NGR3NDBvMC1NWWRadmJnZld1RzB0N2Q4eGQ4OThqV1RQUFlscTBSQ09kMFpkSUlJLXhSbjJOTGMyemtPRWFVOVpTamtFQjJzNDZySmViQzlOb1BPYmtwOVI1SjFwZWVBaHdTUFdTZ0NENWxMUHZQbC1HR3dUUQ?oc=5","date":"2013-12-11","type":"trial","source":"PR Newswire","summary":"Absorption Pharmaceuticals and Kaiser Permanente Initiate Clinical Trial of Promescent® - PR Newswire","headline":"Absorption Pharmaceuticals and Kaiser Permanente Initiate Clinical Trial of Promescent®","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}